期刊文献+

螺内酯对老年高血压并发舒张性心力衰竭的疗效观察 被引量:4

暂未订购
导出
摘要 目的观察螺内酯对老年高血压并发舒张性心力衰竭的疗效并探讨相关的机制。方法通过6 min步行试验和超声心动图指标E峰、A峰、E/A比值变化,并监测Ⅲ型前胶原氨基端肽(PIIINP)和血浆脑钠肽(BNP),比较常规组(n=50)和螺内酯组(n=49)对老年高血压并发舒张性心力衰竭(DHF)患者的临床疗效。结果治疗前2组各项观察指标比较差异无统计学意义(P>0.05),治疗后螺内酯组各项观察指标优于治疗前(P<0.01),并优于常规组(P<0.01)。结论螺内酯对老年高血压并发舒张性心力衰竭的疗效显著。
出处 《疑难病杂志》 CAS 2010年第9期674-675,共2页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献9

二级参考文献69

  • 1郭湖坤,陈纪平,陈锦武.慢性心力衰竭1040例病因与治疗方法分析[J].河北医药,2004,26(11):859-860. 被引量:8
  • 2赵思勤,李秋,吴涛,刘小蓉,赵宁,聂晓莉,王勉,胡咏梅.心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义[J].中华心血管病杂志,2005,33(6):502-504. 被引量:40
  • 3王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 4Macintyre L, Capewell S, Steward S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation, 2000, 102: 1126-1131.
  • 5Groenning BA, Nilsson JC, Sondergard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3:699-708.
  • 6Betteneourt P, Ferreira A, Dias P. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail,2000, 6: 306-313.
  • 7Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure : a pilot study. J Card Fail, 2001,7:21-29.
  • 8Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptides predicts treatment outcomes in patients admitted for decompensated heart failure : a pilot study. J Am Coll Cardiol, 2001, 37:386-391.
  • 9Shah MR, Stinnett SS, McNulty SE, et al. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J, 2001, 141 : 908-914.
  • 10Alehagen U, Lindstedt G, Levin LA, et al. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptides (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up pf a primary care population. International .loumal of Carfiology, 2005, 100: 125-133.

共引文献3792

同被引文献29

  • 1张维忠.降压联合治疗的理论和实践问题[J].中华心血管病杂志,2006,34(5):385-386. 被引量:68
  • 2马虹,刘志军.β受体阻滞剂在治疗高血压病中的地位[J].中华心血管病杂志,2006,34(7):660-661. 被引量:22
  • 3刘国仗,于汇民.高血压治疗策略的演化[J].中华心血管病杂志,2006,34(7):668-670. 被引量:45
  • 4Pitt B,Zannad F,Remme W,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J].N Engl J Med,1999,341(10):709-717.
  • 5Zannad F.Mcmurray JJ,Krum H,et al.Eplerenone in patients with systolic heart failure and mild symptoms[J].N Engl J Med,2011,364(1):11-21.
  • 6Pitt B, Zannad F, Remme W J, et al. Effectiveness of spironolactone add- ed to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone E- valuation Study [ RALES ] ) [ J ]. Am J Cardiol, 1996,78 ( 8 ) :902-907.
  • 7Jean N,Adam S.Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure[J].Vasc Health Risk Manag,2011,7(6):353-363.
  • 8Levy DG,Rocha R,Funder JW.Distinguishing the antihypertensive and electrolyte effects of eplerenone[J].J Clin Endocrinol Metab.2004,89(6):2736-2740.
  • 9Sica DA.Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis[J].Heart Fail Rev,2005,10(1):23-29.
  • 10Kramer DG,Trikalinos TA.Kent DM.et al.Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction:a Meta-Analytic approach[J].J Am Coll Cardiol,2010,56(5):392-406.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部